Molecular subtypes of breast cancer include human epidermal growth factor receptor-2 (HER-2), triple-negative breast cancer (TNBC), estrogen (ER)/progesterone receptor (PR)-positive or -negative molecular subtypes, and luminal A and luminal B [4] ER/PR-positive types of breast cancer are almost 70% of the cases usually reported. Here, ERBB2 is linked to triple-negative breast carcinoma.